Hollander Carel F, Zurcher Chris, Broerse Johan J
Department of Clinical Oncology LUMC, Leiden University Medical Center, Leiden, The Netherlands.
Toxicol Pathol. 2003 Mar-Apr;31(2):209-13. doi: 10.1080/01926230390183698.
In the early sixties, studies have been performed at the TNO-Institutes for Health Research on acute effects of high dose total body irradiation (TBI) with X-rays and fission neutrons in Rhesus monkeys and the protective effect of autologous bone marrow transplantation (BMT). The surviving animals of this study were kept to investigate late radiation effects, ie, tumorigenesis. TBI in combination with chemotherapy, followed by rescue with BMT is increasingly used for the treatment of hematological malignancies and refractory autoimmune disease. The risk of radiation carcinogenesis after this treatment is of growing concern in man. Studies on tumor induction in nonhuman primates are of relevance in this context since the response of this species to radiation does not differ much from that in man. The group of long-term surviving monkeys comprised nine neutron irradiated animals (average total body dose 3A Gy, range 2.3-4.4 Gy) and 20 X-irradiated monkeys (average total body dose 7.1 Gy, range 2.8-8.6 Gy). A number of 21 age-matched nonirradiated Rhesus monkeys served as a control-group. All animals wereregularly screened for the occurrence of tumors. Complete necropsies were performed after natural death or euthanasia. At postirradiation intervals of 4-21 years an appreciable number of malignant tumors was observed. In the neutron irradiated group eight out of nine animals died with 1 or more malignant tumors. In the X-irradiated group this fraction was 10 out of 20. The tumors in the control group, in seven out of 21 animals, appeared at much older age compared with those in the irradiated cohorts. The histogenesis of the malignant tumors was diverse, as was the case for benign tumors. The observed shortening of latency periods and life span, as well as, the increase of mean number of tumors per tumor bearing animal for benign neoplasms parallels the trend observed for malignant tumors. The results of this study were compared to other radiation late effects after TBI followed by different BMT treatment modalities in Rhesus monkeys. The observation that the carcinogenic risk of TBI in the Rhesus monkeys is similar to that derived from the studies of the Japanese atomic bomb survivors and the increase of the risk by a factor of 8 emphasizes the need for regular screening for secondary radiation-induced tumors in long-term surviving patients after TBI followed by BMT.
20世纪60年代初,荷兰应用科学研究院健康研究所在恒河猴身上开展了关于大剂量全身照射(TBI)X射线和裂变中子的急性效应以及自体骨髓移植(BMT)保护作用的研究。该研究中存活下来的动物被留作观察晚期辐射效应,即肿瘤发生情况。TBI联合化疗,随后进行BMT救援,越来越多地用于治疗血液系统恶性肿瘤和难治性自身免疫性疾病。这种治疗后辐射致癌的风险在人类中越来越受到关注。在这种情况下,对非人类灵长类动物进行肿瘤诱发研究具有重要意义,因为该物种对辐射的反应与人类的反应差异不大。长期存活的猴子组包括9只接受中子照射的动物(平均全身剂量3A Gy,范围2.3 - 4.4 Gy)和20只接受X射线照射的猴子(平均全身剂量7.1 Gy,范围2.8 - 8.6 Gy)。21只年龄匹配的未受照射的恒河猴作为对照组。所有动物都定期筛查肿瘤的发生情况。在自然死亡或安乐死后进行完整的尸检。在照射后的4至21年期间,观察到相当数量的恶性肿瘤。在接受中子照射的组中,9只动物中有8只死于1种或多种恶性肿瘤。在接受X射线照射的组中,这一比例为20只中的10只。对照组中,21只动物中有7只出现肿瘤,其出现年龄比照射组的动物大得多。恶性肿瘤的组织发生是多样的,良性肿瘤也是如此。观察到的潜伏期缩短和寿命缩短,以及每只患肿瘤动物的良性肿瘤平均数量增加,与恶性肿瘤观察到的趋势相似。本研究结果与恒河猴在接受TBI后采用不同BMT治疗方式的其他辐射晚期效应进行了比较。恒河猴中TBI致癌风险与日本原子弹幸存者研究得出的结果相似,且风险增加了8倍,这一观察结果强调了对TBI后接受BMT的长期存活患者定期筛查继发性辐射诱发肿瘤的必要性。